Trex

TRex Bio 完成了 5000 万美元的融资，这家生物技术公司将利用这笔资金推进其临床和临床前项目，其中最主要的是其专门设计的 TNFR2 激动剂 TRB-061。该候选药物目前正在进行针对特应性皮炎的 Ia/b 期临床试验，旨在选择性地激活影响皮肤和其他屏障组织的炎症性疾病中的调节性 T 细胞 (Treg)。
...

$Trex(TREX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-306027  Act: 34  Size: 209 KB 网页链接

$Trex(TREX)$ 8-K/A [Amend] Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-306089  Act: 34  Size: 398 KB 网页链接

$Trex(TREX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001069878-25-000026  Size: 4 KB 网页链接

$Trex(TREX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001069878-26-000002  Size: 4 KB 网页链接

$Trex(TREX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001069878-26-000004  Size: 4 KB 网页链接

$Trex(TREX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000080255-25-000804  Act: 34  Size: 7 KB 网页链接

$Trex(TREX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001069878-25-000028  Size: 2 KB 网页链接

$Trex(TREX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001069878-25-000030  Size: 4 KB 网页链接